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Background: Warfarin is the most commonly prescribed oral anticoagulant for the prevention 
and treatment of venous thromboembolism. Due to its narrow therapeutic index, warfarin requires 
close monitoring of the international normalized ratio (INR) to ensure proper anticoagulation 
control and safety. INRs outside of this range are strongly associated with an increased risk of 
major bleeding, thromboembolic events, and death. Patient self-testing (PST) using a point-of-
care device allows patients to monitor INR results at home. Evidence shows that PST improves 
the clinical outcomes of warfarin therapy compared to usual care, which includes laboratory INR 
monitoring. Purpose: To compare the clinical effectiveness of INR patient self-testing in adults 
on warfarin therapy versus usual care in an internal medicine practice. Conclusions: On average, 
PST achieved tighter anticoagulation control compared to usual care. PST provided more 
consistent and less variable INR results within the therapeutic range. These findings are clinically 
and statistically significant, suggesting the clinical efficacy of PST. Clinical Implications: These 
outcomes warrant the comparison of different INR meters, in terms of patient choice and 
satisfaction.  











Warfarin is the most commonly prescribed oral anticoagulant for the prevention and 
treatment of venous thromboembolism associated with chronic atrial fibrillation and mechanical 
heart valves [1]. Due to its narrow therapeutic index, warfarin requires regular monitoring of the 
international normalized ratio (INR) to ensure proper anticoagulation control [2]. The INR 
therapeutic range for anticoagulation therapy is between 2.0 and 3.0, except for mechanical heart 
valves, which require an INR between 2.5 and 3.5. INRs outside of this range are strongly 
associated with an increased risk of major bleeding, thromboembolic events, and even death [3]. 
Laboratory monitoring of warfarin therapy, known as usual care, includes repeated venous 
punctures to obtain INR results and subsequent dose adjustments by the health care provider [4].   
Using conventional measures, frequency of INR monitoring is problematic in ambulatory 
care. A research study showed that gaps in monitoring during warfarin therapy are associated 
with poor anticoagulation control and adverse events [5]. The data related gaps to non-adherence 
with INR monitoring and identified patient-level predictors, which included poverty, driving 
distance, dementia, depression, and nonwhite race. Another study evaluated patient non-
adherence to standard INR testing and found that the rate of thromboembolic events was higher in 
the non-adherent group compared to the adherent group [6]. Non-adherence to INR monitoring is 
a common and significant barrier to proper anticoagulation control.  
The option of patient self-testing (PST) using a point-of-care (POC) device has 
eliminated some of these barriers by enabling patients to test their INR levels at home via a 
fingerstick blood sample, compared to outpatient visits to a laboratory or clinic. The POC device 
communicates the INR result to the patient’s provider wirelessly, through a secured website, and 
the provider adjusts the patient’s warfarin dose accordingly. Another option of patient self-
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management (PSM) is available, in which patients are trained to self-test and interpret the INR 
result for dose adjustment.  
Systematic reviews have shown PST/PSM to be superior to usual care with fewer 
bleeding events and thromboembolic events, as well as reduced overall mortality [7-11]. 
Therefore, evidence-based clinical practice guidelines recommend PST/PSM to all suitable 
patients receiving oral anticoagulation therapy [3, 12]. In this study, PST alone was implemented 
and its effects analyzed.  
Methods 
Scope of the Problem 
In January 2010, the clinical problem of non-therapeutic INRs in patients receiving 
warfarin therapy was identified at a private practice setting in the southwest region of the United 
States. The scope of the problem was appreciated after collecting INR results from contracted 
laboratories over a 15-month period and calculating the average INR per quarter, or every three 
months. Infrequent and inconsistent INR testing was the main factor contributing to non-
therapeutic levels. Therefore, PST was proposed as a solution to the problem.  
Patient Recruitment 
The practice setting’s providers offered PST to patients if they met the following 
inclusion criteria: indication for long-term warfarin therapy, such as chronic atrial fibrillation, 
mechanical heart valve, and/or history of deep vein thrombosis; taking warfarin for at least 6 
months; and willingness to participate in PST. Exclusion criteria included inability to perform the 
test, due to factors such as poor coordination with hand tremor or poor visual acuity, and denial of 





Providers referred eligible patients to the practice setting’s nurse practitioner who 
provided hands-on device training during a 45- minute consultation appointment. At the end of 
the appointment, the nurse practitioner assessed the patient’s competency via a return 
demonstration. At the conclusion of the visit, the nurse practitioner provided the patient with a 
meter reference manual as well as contact information if questions or problems occurred.  
Online System 
Once the POC device was received, all participating patients were instructed to test their 
INR level at least once a week for the first month, or until therapeutic, and biweekly thereafter. 
INR results were communicated to the provider via fax, phone call, and wirelessly through a 
secured online system. If the result was above or below the prescribed therapeutic range, the 
online system alerted the provider via phone call, requesting the provider to contact the patient 
within 24 hours for warfarin dose adjustment. Provider telephone support was available to the 
patients at all times.  
 Patients and providers were able to access the online system to view INR results. The 
system also stored patient information such as demographics, indication for therapy, insurance 
carrier information, provider, and past INR results. Information was only available to patients and 
providers through a password-protected website.   
Data Collection 
 Patient data were collected and analyzed from January 2010 to September 2014. Patient 
data, including age, gender, indication for warfarin therapy, INR results, provider, and insurance 
carrier, were collected from electronic medical records. Regardless of each patient’s start date, 
INR results were collected for at least six months before and after PST implementation. Using 
9 
 
Microsoft excel, INR results were organized by pre and post-PST implementation and the 
averages were calculated every three months (quarterly) for data concision. INR averages were 
analyzed using QI Macros software and X-bar-S control charts were created.  
Results  
Of the 36 patients recruited for this project from January 2010 to September 2014, eight 
patients were excluded due to PST noncompliance, no longer being patients of the practice, or 
death. A total of twenty-eight patients remained and were included in the analysis.  





Table 1 provides descriptive information about the sample used in the analysis. Males 
made up 54% of the patients, and the average age of patients was 72 years (range 27 to 91 years). 
In laboratory monitoring, 25 out of 28 patients had their INRs measured an average of 9 times 
before receiving the meter for PST monitoring. During meter monitoring, all 28 patients 
measured their INRs 88 times, on average, which is significantly greater than laboratory 
monitoring frequency (p<0.001). Overall, PST increased the frequency of INR monitoring.  
Group 
# of 
observations Mean Min Max 
Males 28 0.54 0.00 1.00 
Age  28 71.80 26.84 91.31 
Lab INR measurements 25 8.96 1.00 33.00 
Meter INR measurements 28 87.93 7.00 228.00 
     
 
Fig. 1 X-bar-S Control Chart Displaying Process Control for Laboratory Versus Metered INR 
Monitoring 
The X-bar-S control chart plots the process mean and process standard deviation for 
patients to help determine the stability of INR measurements over time. The X
is reported in Figure 1 and serves as an indicator of whether PST provided
consistent process over time compared to usual care. The dashed vertical line represents the point 
at which PST was implemented and metered monitoring began, separating the laboratory INR 
measurements from the metered INR measurements. In 
is partitioned into quarters with an “L” preceding the quarter number if data were collected when 
patients were monitoring their INRs in a laboratory setting or an “M” preceding the quarter 
number if data were collected using metered monitoring to measure their INRs. The mean of 
INRs is represented by the middle turquoise line, which shows an INR mean measurement of 
approximately 2.5 in laboratory monitoring as compared with an INR mean measurement of 
approximately 2.4 in metered monitoring. The upper and lower control limits are calculated as 
three standard deviations above and below the mean, respectively. These limits are represented by 
two red lines indicating an upper limit of 3.4 and a lower limit of 1.6 in la
compared with an upper limit of 2.8 and a lower limit of 2.1 in metered monitoring. The 
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narrowing of control limits towards the therapeutic range over time (from laboratory monitoring 
to metered monitoring) indicates that metered mon
patients’ INR measurements within a desirable range. In comparison, laboratory monitoring has a 
larger spread between its upper and lower control limits with variable results, suggesting a poorly 
controlled process. In sum, average INRs in PST using metered monitoring are better controlled 
than in usual care using laboratory monitoring. Overall, Figure 1 shows that metered monitoring 
is associated with a more stable process as compared with laboratory monitoring
INR measurements occurring within a more desirable range. 
Fig. 2 X-bar-S Control Chart Displaying Process Consistency of Laboratory Versus Metered INR 
Monitoring 
Figure 2 depicts the relative consistency of INR results by comparing the s
deviations of laboratory data with those for metered monitoring. In the laboratory monitoring 
phase, represented by quarters L1 to L5, there is more variation as seen by the larger upper and 
lower controls limits as compared with the metered monito
quarters M1 to M17. After PST implementation, depicted by the dashed line, there is less 
variation in the metered monitoring phase as indicated by the narrower upper and lower control 
limits. The red points indicate stat
11 
itoring is associated with greater control of 
ring phase, which is represented by 
istical significance, which are seen immediately in quarters M1 





and M2. The trend of red points seen in quarters M6 to M12, indicates consistent and statistically 
significant INR results. Although consistency slips in M3 to M5 and again after M13, metered 
monitoring still provides dramatically more consistent INR results compared to the INR results 
collected during laboratory monitoring. 
Discussion 
 The results of this analysis provide insight to the quality of INR control in patients who 
self-test, as well as the clinical efficacy of warfarin therapy. Additionally, the data from the 
analysis allows a comparison of the quality of INR control between PST and usual care.   
Since major adverse events and death could not be attributed to a confirmable cause in 
the data, no analysis on the rate of major thromboembolic or bleeding events could be completed. 
Thus, it is not possible to compare the rate of events in this data to the rate of newer oral 
anticoagulants reported in studies. Furthermore, this analysis is based on data collected in clinical 
practice, not in  the controlled setting of a randomized controlled trial.    
 The mean frequency of INR testing was higher in PST using metered monitoring (88 
times) than in usual care using laboratory monitoring (9 times). Testing frequency is strongly 
correlated with INR control. Therefore, PST was found to be more efficient in maintaining INR 
control and potentially reducing major adverse and fatal events, compared to usual care. 
Moreover, the frequency of critical INR values is an important indicator of the effectiveness of 
warfarin therapy. Critical INR values are defined as those below 1.5, carrying a major risk of a 
thromboembolic event, and those above 5.0, carrying a major risk for a bleeding event [13, 14]. 
In Figure 1, the frequency of near-critical values is observed in the laboratory (usual care) data set 
with the lower control limit of 1.6.  There are no critical values seen in the metered (PST) data set 
as the lower and upper control limits are within therapeutic range, 2.1 and 2.8, respectively. This 
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suggests that PST is able to achieve tighter INR control within the defined therapeutic range of 
2.0 to 3.0.   
Conclusion  
 Overall, this project showed that PST was clinically more effective in INR monitoring 
than usual care in our internal medicine practice. PST achieved tight INR control within 
therapeutic range, improved therapeutic efficacy of warfarin, and enhanced treatment safety for 
patients. Thus, PST should be offered and recommended as a vital element of INR monitoring of 
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EFFECTIVENESS OF INR PATIENT SELF-TESTING: ADULTS ON WARFARIN 
THERAPY IN INTERNAL MEDICINE 
 
PURPOSE:  
To compare the clinical effectiveness of INR patient self-testing in adults on warfarin therapy 
versus usual care in an internal medicine practice.  
 
BACKGROUND: 
Warfarin is the most commonly prescribed oral anticoagulant for the prevention and treatment of 
venous thromboembolism. Due to its narrow therapeutic index, warfarin requires close 
monitoring of the international normalized ratio (INR) to ensure proper anticoagulation control 
and safety. INRs outside of this range are strongly associated with an increased risk of major 
bleeding, thromboembolic events and even death. Patient self-testing (PST) using a point-of-care 
device allows patients to monitor their INR results from home. Evidence shows that PST 
improves the clinical outcomes of warfarin therapy compared to usual care, which includes 
laboratory INR monitoring. 
 
METHODS:  
Included competent and motivated adult patients with AF and/or DVT taking warfarin therapy for 
at least 6 months. Excluded those unable to self-test or denied health insurance coverage for PST-
related expenses. The clinic Nurse Practitioner provided hands-on meter training and set-up to 
eligible patients. Competency and willingness to participate were assessed. Age, gender, 
insurance carrier, provider, indication for warfarin therapy and INR results were collected from 
January 2010 to September 2014. Quarterly INR averages (every 3 months) were calculated for 
data concision using Microsoft Excel. Control charts were created using QI Macros to compare 
laboratory INR data (usual care) to meter INR data (PST).  
 
OUTCOMES: 
In laboratory (usual care) monitoring, control limits are wide and INR results are variable, no 
statistically significant INR averages resulted. In meter (PST) monitoring, control limits are 
narrow and INR results are tightly controlled, resulting in statistically significant INR averages.  
 
CONCLUSIONS:  
Compared to usual care, PST resulted in tighter control of patients’ INR measurements within a 
desirable range. PST provides a consistent process as well as a higher frequency of INR testing. 
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